Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis

✍ Scribed by Yu Xuan Koo; Matthew Tay; Yii Ean Teh; David Teng; Daniel S. W. Tan; Iain B. H. Tan; David W. M. Tai; Richard Quek; Miriam Tao; Soon Thye Lim

• Publisher: Springer
• Year: 2011
• Tongue: English
• Weight: 92 KB
• Volume: 90
• Category: Article
• ISSN: 0939-5555
• DOI: 10.1007/s00277-011-1241-0